Showing results (111-120 of 261) with videos related to
Sort By:
Pageof 27
Current Medical Research and Opinion|December 31, 2016
Treatment of postherpetic neuralgia with 5% lidocaine medicated plaster in elderly patients - subgroup analyses from three European clinical trialsRainer Sabatowski, Irmgard Bösl, Simone König, et al.Current Medical Research and Opinion|June 2, 2009
Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathyRalf Baron, Victor Mayoral, Göran Leijon, et al.Pain Practice : the Official Journal of World Institute of Pain|April 23, 2014
Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open-label Continuation Arm of a Randomized Phase 3b StudyRalf Baron, Uwe Kern, Matthias Müller, et al.Clinical Drug Investigation|March 24, 2009
Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trialRalf Baron, Victor Mayoral, Göran Leijon, et al.Current Medical Research and Opinion|April 16, 2009
Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term studyGuy Hans, Rainer Sabatowski, Andreas Binder, et al.Pain Reports|February 14, 2024
The role of cytokines and chemokines in the maintenance of chronic pain-a pilot studyJosephine Lassen, Frank Leypoldt, Philipp Hüllemann, et al.Current Medical Research and Opinion|November 30, 2013
High concentration capsaicin for treatment of peripheral neuropathic pain: effect on somatosensory symptoms and identification of treatment respondersJohanna Höper, Stephanie Helfert, Marie-Luise S Heskamp, et al.Pain Practice : the Official Journal of World Institute of Pain|April 18, 2014
Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double-blind, Phase 3b StudyRalf Baron, Emilio Martin-Mola, Matthias Müller, et al.Pain|March 27, 2012
Different underlying pain mechanisms despite identical pain characteristics: a case report of a patient with spinal cord injuryAndrea Westermann, Elena K Krumova, Werner Pennekamp, et al.Pain|October 18, 2023
Efficacy and safety of eliapixant in diabetic neuropathic pain and prediction of placebo responders with an exploratory novel algorithm: results from the randomized controlled phase 2a PUCCINI studyDidier Bouhassira, Solomon Tesfaye, Arnab Sarkar, et al.Pageof 27